Oren M. Becker

Part of Applied Materials, Inc., Orbot Instruments, Inc. is an Israeli company that makes optical systems that inspect patterned silicon wafers. The company is based in Yavine, Israel. The company was founded by Zvi Lapidot. Orbot Instruments was acquired by Applied Materials, Inc. on January 10, 1997 for $110 million.

Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA.

Orgenics Ltd. develops medical diagnostic test kits for the diagnosis of infectious diseases. Its products include RapidTest, DoubleCheck, DoubleCheckGold, Clinical Chemistry, Indirect Peroxidase, Point of Care DrugCheck, BioAssay Systems, Microbiology, Veterinary and MediScreen Pipettes. The company was founded in 1982 and is headquartered in Yavne, Israel.

Warburg Pincus & Company US LLC engages in the provision of investment services. The company is headquartered in New York, NY.

Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel.

The Cancer Institute of New Jersey operates as a cancer centre. The firm offers cancer care for adults and children, providing access to the medicines and treatment options. It also offers clinical, patient education resources and support services. The company was founded in and is headquartered in New Brunswick, NJ.

Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ.

Part of The European Molecular Biology Laboratory, EMBL Enterprise Management Technology Transfer GmbH is an alternative investment manager. The company is based in Heidelberg, Germany. The German company was founded in 1999. The CEO is Gabor M. Lamm.

BioCep Ltd. develops cell separation technologies. The firm also manufactures and sells cutting-edge technologies for cell isolation. Its product, SmartSep enables cell recovery with magnetic beads removal process before infusion to the patient. The company was founded by Ofer Klein and Aharon Lamish on July 4, 2006 and is headquartered in Ness Ziona, Israel.

Office of Technology Development (Office of Technology Development) is a venture capital subsidiary of Harvard University founded in 2007. The firm is headquartered in Cambridge, Massachusetts.

Orbotech, Inc. provides yield-enhancing and production solutions for printed circuit boards and IC substrates. The company was founded on February 21, 1984 and is headquartered in Billerica, MA.

The Israel National Nanotechnology Initiative provides federal program for engineering, science, and technology research. The company is headquartered in Tel Aviv, Israel.

Pixcell Medical Technologies Ltd. develops, produces, and markets portable medical diagnostic products for point of care testing. Its product is HemoScreen. The company was founded by Max Herzberg and Avishay Bransky on June 3, 2008 and is headquartered in Yokneam Ilit, Israel.

SPTS Technologies Ltd. manufactures plasma etch and deposition and thermal processing equipment for the semiconductor industry. Its products include plasma dicing, HF release etch, XeF2 release etch, metal deposition, MVD, PECVD and inkjet printing for IC. The company was founded in 2009 and is headquartered in Newport, the United Kingdom.

Part of KLA Corp., Orbotech Holding UK Ltd. operates as a holding company that provides management services through its subsidiaries. The company is based in Newport, UK.

Part of KLA Corp., SPTS Technologies UK Ltd. is a company that manufactures semiconductor capital equipment. The company is based in Newport, UK.

Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel.

Part of New York University, New York University Medical Center is a healthcare provider that offers personalized treatment for reproductive and sexual health conditions in men and women. The company is based in New York and provides emergency and urgent care at various locations, as well as Virtual Urgent Care. NYU Langone's Community Health Needs Assessment and Service Plan aims to support behavior change and disease prevention at the neighborhood level. The American company was founded by J. Ira Harris.

Israel Amplify Program Corp. is a blank check company. It engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on March 5, 2021 and is headquartered in New York, NY.

Airovation Technologies Ltd. is an air-tech company based in Ness Ziona, Israel. Airovation Technologies provides patented air purification and carbon capture solutions that can efficiently and economically capture and convert CO2 into valuable mineral end-products and oxygen. The Israeli company's technology can also purify indoor air spaces by oxidizing dangerous microbiological threats such as viruses and bacteria while converting harmful gases into oxygen-enriched clean air. The key technological breakthrough is the in-situ generation of superoxide radical, the strongest oxidizer in nature, which creates high purity carbonates and bicarbonates for carbon capture and utilization solutions. The company was founded by Marat Maain and Gil Tomer, with Marat Maain serving as CEO since incorporation.

Nanocarry Therapeutics Ltd. is a company based in Nes-Ziona, Israel. Nanocarry is developing a new class of therapeutics using bioengineered nanoparticles to treat oncology indications and brain diseases. The Israeli company's proprietary "plug and play" approach allows for easy modification to deliver a wide array of biologics safely and effectively to the brain and beyond. Nanocarry's first products in development are for brain metastases of HER2+ breast cancer and non-small cell lung cancer. The company aims to extend the reach of biological therapeutics to the brain to tackle CNS diseases head-on, pioneering a multidisciplinary approach that overcomes the blood-brain barrier. The company was founded by Rachela Popovtzer, Oshra Betzer, and Revital Mandil-Levin, with Revital Mandil-Levin serving as the CEO since incorporation.